SOCS1 and autoimmune thrombocytopenic purpura: Inhibition of SOCS1 promoted the progression of ITP by blocking the PDL/PDI pathway, while upregulation of miR-155-5P increases platelet abundance and downregulates expression of SOCS1 [54].